← Eichor
Study identifier: NCT06414031 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Condition: Surgical Blood Loss · Transfusion-dependent Anemia · Abdomen Disease  ·  Sponsor: Ulrich Ronellenfitsch, MD

PhasePhase 3
Planned participants850
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if the administration of tranexamic acid can reduce the necessity of blood transfusions in adult patients undergoing major abdominal surgery. . It will also inform about safety of tranexamic acid in this setting. The main question it aims to answer is: Does tranexamic acid lower the probability of receiving at least one blood transfusion during or after surgery? Participants will compare tranexamic acid o a placebo (a look-alike substance that contains no drug) to see if tranexamic acid works to reduce the necessity of a blood transfusion.

This description comes directly from the study's public registry record.

Talk to the study team

Ulrich Ronellenfitsch, MD  ·  +493455572327  ·  ulrich.ronellenfitsch@uk-halle.de

Always discuss trial participation with your own doctor first.

Locations (2)

University Hospital Carl Gustav Carus DresdenDresden, Saxony, GermanyRecruiting
University Hospital, Dpt. of Abdominal, Vascular and Endocrine SurgeryHalle, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06414031